End Stage Renal Disease (ESRD)
Also known as: End-Stage Renal Disease (ESRD) / ESRD / End- Stage Renal Disease Patients / ESRD (End-Stage Renal Disease) / End Stage Renal Disease Patients / End-Stage Renal Disease / Endstage Renal Disease / Endstage Kidney Disease / End Stage Kidney Disease / End Stage Renal Disease / End Stage Renal Diseases / End-Stage Kidney Disease / Chronic kidney disease (CKD) / Chronic renal failure syndrome (disorder) / Renal failure chronic / Renal failure: [chronic] or [end stage] / Chronic renal failure / Kidney failure chronic / Kidney Failure, Chronic / End stage renal failure / End-stage renal disease (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB08907 | Canagliflozin | A sodium-glucose co-transporter 2 (SGLT2) inhibitor used to manage hyperglycemia in type 2 diabetes mellitus (DM). Also used to reduce the risk of major cardiovascular events in patients with established cardiovascular disease and type 2 DM. |
| DB06292 | Dapagliflozin | A sodium-glucose cotransporter 2 inhibitor used in the management of type 2 diabetes mellitus. |
| DB16165 | Finerenone | A nonsteroidal mineralocorticoid receptor antagonist indicated to lower the risk of eGFR decline, end stage kidney disease, cardiovascular death, heart attack, and hospitalization for heart failure in chronic kidney disease associated with type 2 diabetes. |
| DB06792 | Lanthanum carbonate | A phosphate binder indicated for the reduction of serum phosphate in patients with end stage renal disease. |
| DB00583 | Levocarnitine | A quaternary ammonium compound used to treat carnitine deficiency or to stimulate gastric and pancreatic secretions in hyperlipoproteinemia. |
| DB00331 | Metformin | A biguanide antihyperglycemic used in conjunction with diet and exercise for glycemic control in type 2 diabetes mellitus. It is also used off-label for insulin resistance in polycystic ovary syndrome (PCOS). |